R. Cosman

发表论文 43 篇 · 总被引 371 次 · h-index 9

代表论文

Phase 1/2 Study of the Indoleamine 2,3-Dioxygenase 1 Inhibitor Linrodostat Mesylate Combined With Nivolumab or Nivolumab and Ipilimumab in Advanced Solid Tumors or Hematologic Malignancies. (2024 · Clinical Cancer Research · 被引 15)
First-in-human mRNA CAR therapy: Correlative biomarker analysis from the MT-302 phase 1 study targeting TROP2 in patients with advanced epithelial tumors. (2025 · Journal of Clinical Oncology · 被引 13)
Pan-tumor activity of olomorasib, a next-generation KRAS G12C inhibitor in KRAS G12C-mutant advanced solid tumors: a first-in-human study (2026 · Nature Communications · 被引 11)
A phase 2 safety and efficacy study of neoadjuvant/adjuvant darovasertib for localized ocular melanoma. (2024 · Journal of Clinical Oncology · 被引 10)
Final Results from a First-in-Human Phase 1 Study of the Dual Isocitrate Dehydrogenase (IDH) 1/2 Inhibitor, LY3410738, in Advanced Solid Tumors Harboring IDH1 or IDH2 Mutations. (2025 · Clinical Cancer Research · 被引 9)
Preliminary phase 1 results of INCB161734, a novel oral Kirsten rat sarcoma (KRAS) G12D inhibitor, as monotherapy or in combination with chemotherapy for advanced/metastatic pancreatic duct adenocarcinoma (PDAC). (2026 · Journal of Clinical Oncology · 被引 8)